Profil
Philipp Bürling is the founder and Chief Financial Officer of NUMAFERM GmbH, which is founded in 2017.
He is currently the Chief Executive Officer of Priavoid GmbH.
Postes actifs de Philipp Bürling
| Sociétés | Poste | Début |
|---|---|---|
NUMAFERM GmbH
 NUMAFERM GmbH BiotechnologyHealth Technology NUMAFERM GmbH specializes in the biotechnical production of peptides. The firm focuses on pharmaceutical, antimicrobial and adhesives peptides. Its services include feasibility study, custom synthesis, peptide development, up scaling, and licensing services. The company was founded by Philipp Bürling and Karl Christian Werner Schwarz in January 2017 and is headquartered in Dusseldorf, Germany. | Fondateur | 01/01/2017 |
Priavoid GmbH
 Priavoid GmbH Pharmaceuticals: MajorHealth Technology Priavoid GmbH develops therapies for neurological diseases. The company is based in Düsseldorf, Germany. The German company was founded in 2017. The CEO is Philipp Bürling. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
NUMAFERM GmbH
NUMAFERM GmbH BiotechnologyHealth Technology NUMAFERM GmbH specializes in the biotechnical production of peptides. The firm focuses on pharmaceutical, antimicrobial and adhesives peptides. Its services include feasibility study, custom synthesis, peptide development, up scaling, and licensing services. The company was founded by Philipp Bürling and Karl Christian Werner Schwarz in January 2017 and is headquartered in Dusseldorf, Germany. | Health Technology |
Priavoid GmbH
Priavoid GmbH Pharmaceuticals: MajorHealth Technology Priavoid GmbH develops therapies for neurological diseases. The company is based in Düsseldorf, Germany. The German company was founded in 2017. The CEO is Philipp Bürling. | Health Technology |